Back to Search
FRANK SASSE, MD
MD
Anesthesiology Physician
NPI: 1922074442Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
20240(WI)
Research & Publications (20)
New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis.
PMID 19554593·Chembiochem·2009
8-other
Metal complexes of natural melophlins and their cytotoxic and antibiotic activities.
PMID 18951635·J Inorg Biochem·2009
8-other
Multicomponent reactions for the synthesis of multifunctional agents with activity against cancer cells.
PMID 19641815·Chem Commun (Camb)·2009
7-preclinical
Highly active ansamitocin derivatives: mutasynthesis using an AHBA-blocked mutant.
PMID 18381586·Chembiochem·2008
8-other
The first cyclic monomeric 3-alkylpyridinium alkaloid from natural sources: identification, synthesis, and biological activity.
PMID 18931812·Org Biomol Chem·2008
7-preclinical
Synthesis and biological evaluation of cruentaren A analogues.
PMID 18306263·Chemistry·2008
7-preclinical
Semisynthesis and antiplasmodial activity of the quinoline alkaloid aurachin E.
PMID 18922036·J Nat Prod·2008
7-preclinical
Synthesis and biological properties of cylindramide derivatives: evidence for calcium-dependent cytotoxicity of tetramic acid lactams.
PMID 18798209·Chembiochem·2008
7-preclinical
Chondramide C: synthesis, configurational assignment, and structure-activity relationship studies.
PMID 18624309·Angew Chem Int Ed Engl·2008
7-preclinical
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
PMID 18598941·Cancer Cell·2008
7-preclinical
First syntheses of melophlins P, Q, and R, and effects of melophlins on the growth of microorganisms and tumor cells.
PMID 19035571·Chem Biodivers·2008
7-preclinical
Total synthesis and biological activity of neopeltolide and analogues.
PMID 18979467·Chemistry·2008
7-preclinical
The first hydroxylated archazolid from the myxobacterium Cystobacter violaceus: isolation, structural elucidation and V-ATPase inhibition.
PMID 17551213·J Antibiot (Tokyo)·2007
7-preclinical
Complete genome sequence of the myxobacterium Sorangium cellulosum.
PMID 17965706·Nat Biotechnol·2007
8-other
Efficient one-pot synthesis of biologically active polysubstituted aromatic amines.
PMID 17870540·Bioorg Med Chem·2007
7-preclinical
Design, synthesis, and biological properties of highly potent tubulysin D analogues.
PMID 17828721·Chemistry·2007
8-other
Prismatomerin, a new iridoid from Prismatomeris tetrandra. Structure elucidation, determination of absolute configuration, and cytotoxicity.
PMID 17665951·J Nat Prod·2007
8-other
Cruentaren A, a highly cytotoxic benzolactone from Myxobacteria is a novel selective inhibitor of mitochondrial F1-ATPases.
PMID 17624334·FEBS Lett·2007
7-preclinical
Evidence for the mode of action of the highly cytotoxic Streptomyces polyketide kendomycin.
PMID 17592829·Chembiochem·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1214 WELLESLEY RD
MADISON, WI 53705 - Phone
- (608) 231-1859
Quick Facts
- NPI
- 1922074442
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile